X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…